chartexchange

Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)

GlobeNewswire Inc. | Nov 19, 2026 7:30 AM EST

EMPD is a serious, rare, and life-threatening genital and perianal skin cancer 

Read original article